Tempus AI vs Exa
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
|
|
Exa
Web search and retrieval API built for AI agents and apps
Visit
|
|
|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 7.7 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Freemium |
| Free tier | No free tier; enterprise contracts only | 20,000 search requests per month on the free plan; startup and education grants of $1,000 in free API credits also available |
| Paid from | Custom enterprise contracts; multi-year data-licensing subscriptions (price not publicly disclosed) | API search billed at $7 per 1,000 requests (as of March 2026 pricing update) |
| Has API | ✓ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✓ |
| Users | ~50% of US oncologists; 4,500+ hospital integrations; 40M+ clinical records | — |
| Founded | 2015 | 2021 |
| Maker | Tempus AI, Inc. (independent, Nasdaq: TEM) | — |
| Verdict | Tempus AI is among the most data-rich precision oncology platforms in existence, with a self-reinforcing flywheel of clinical sequencing, molecular data, and real-world outcomes that no pure-software competitor can easil... |
Exa is a credible, fast-moving entrant in the agent-search space, with a clean API, MCP support and strong investor backing as of 2026. It competes directly with Parallel and Tavily on freshness and structured retrieval... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.